BiotechTube
Home/Abcuro/Alex Martin
AM

Alex Martin

Chief Executive Officer

Abcuro

Therapeutic Areas

Autoimmune DiseasesOncologyRare Diseases

Abcuro Pipeline

DrugIndicationPhase
UlviprubartInclusion Body Myositis (IBM)Phase 2/3

Leadership Team at Abcuro

CC
Courtney Cupples
Chief Commercial Officer
View full Abcuro profile